Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 17690897)

Published in Graefes Arch Clin Exp Ophthalmol on August 10, 2007

Authors

Eun Jee Chung1, Ji Hyun Kim, Hyun Seok Ahn, Hyoung Jun Koh

Author Affiliations

1: The Institute of Vision Research, Department of Ophthalmology,Yonsei University College of Medicine, Seoul, South Korea.

Articles citing this

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med (2011) 7.37

Screening and Treatment in Retinopathy of Prematurity. Dtsch Arztebl Int (2015) 1.26

Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels. Graefes Arch Clin Exp Ophthalmol (2010) 1.13

Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res (2009) 1.11

Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol (2013) 1.05

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefes Arch Clin Exp Ophthalmol (2010) 1.04

Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity. Middle East Afr J Ophthalmol (2010) 1.03

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability. J Ophthalmol (2011) 1.02

Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) (2012) 1.00

Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity. Br J Ophthalmol (2014) 0.95

Intravitreal injection of bevacizumab for retinopathy of prematurity. Jpn J Ophthalmol (2014) 0.91

Combination of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity. Case Rep Ophthalmol (2012) 0.91

[Pathogenesis of retinopathy of prematurity]. Ophthalmologe (2012) 0.86

Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey. Graefes Arch Clin Exp Ophthalmol (2014) 0.84

Surgical management of retinopathy of prematurity. Curr Opin Ophthalmol (2008) 0.83

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity. PLoS One (2015) 0.82

Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity. PLoS One (2015) 0.81

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity. J Ophthalmol (2015) 0.78

Application of Arterial Spin Labelling in the Assessment of Ocular Tissues. Biomed Res Int (2016) 0.77

[Intraocular injections of bevacizumab in rare indications--two cases]. Ophthalmologe (2009) 0.77

Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity. Clin Ophthalmol (2015) 0.77

[Pharmacological treatment for retinopathy of prematurity]. Ophthalmologe (2011) 0.75

Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report. Jpn J Ophthalmol (2012) 0.75

Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series. Graefes Arch Clin Exp Ophthalmol (2011) 0.75

Posterior pole sparing laser photocoagulation combined with intravitreal bevacizumab injection in posterior retinopathy of prematurity. J Ophthalmol (2014) 0.75

Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. J Pers Med (2013) 0.75

Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: A case report. Exp Ther Med (2017) 0.75

[Acute retinopathy of prematurity]. Ophthalmologe (2008) 0.75

Articles cited by this

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med (1994) 16.24

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol (2003) 14.41

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A (1995) 5.66

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology (2006) 4.48

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol (2006) 4.09

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol (1996) 3.49

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol (2006) 3.34

Childhood blindness. J AAPOS (1999) 2.75

Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73

Testing intravitreal toxicity of bevacizumab (Avastin). Retina (2006) 2.45

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina (2006) 2.23

Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol (1990) 2.14

Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients. Retina (2006) 1.42

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging (2007) 1.37

Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol (2006) 1.37

Bevacizumab for neovascular ocular diseases. Ann Pharmacother (2007) 1.29

Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. Am J Ophthalmol (2006) 1.27

Vascular endothelial cell growth factors promote the in vitro development of rat photoreceptor cells. J Neurosci (2000) 1.16

Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina (2006) 1.14

Zone I retinopathy of prematurity. J AAPOS (2000) 1.11

Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol (2000) 1.07

Vitreal macrophages express vascular endothelial growth factor in oxygen-induced retinopathy. Clin Experiment Ophthalmol (2000) 1.07

Outcome of zone 1 retinopathy of prematurity. Acta Ophthalmol Scand (2003) 1.00

The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. Lab Invest (1996) 0.91

Articles by these authors

Structure-function relationship and diagnostic value of macular ganglion cell complex measurement using Fourier-domain OCT in glaucoma. Invest Ophthalmol Vis Sci (2010) 2.09

Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics (2009) 1.84

Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology (2010) 1.74

Red light of 647 nm enhances osteogenic differentiation in mesenchymal stem cells. Lasers Med Sci (2008) 1.57

Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma. Leuk Lymphoma (2014) 1.57

Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema. Ophthalmologica (2010) 1.57

Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patients. J Allergy Clin Immunol (2007) 1.57

Elevated free fatty acid is associated with cardioembolic stroke subtype. Can J Neurol Sci (2011) 1.49

Portal hypertensive enteropathy diagnosed by capsule endoscopy in cirrhotic patients: a nationwide multicenter study. Dig Dis Sci (2014) 1.49

Choroidal thickness, age, and refractive error in healthy Korean subjects. Optom Vis Sci (2014) 1.46

High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients. Neurology (2014) 1.40

Lesions on DWI and the Outcome in Hyperacute Posterior Circulation Stroke. Can J Neurol Sci (2014) 1.38

EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles (2013) 1.34

Comparing the ganglion cell complex and retinal nerve fibre layer measurements by Fourier domain OCT to detect glaucoma in high myopia. Br J Ophthalmol (2010) 1.32

Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol (2009) 1.28

Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina (2010) 1.24

A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol (2006) 1.22

Comparison of macular ganglion cell complex thickness by Fourier-domain OCT in normal tension glaucoma and primary open-angle glaucoma. J Glaucoma (2013) 1.20

Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol (2008) 1.20

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2008) 1.20

Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci (2013) 1.17

Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina (2008) 1.17

Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina (2009) 1.14

Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Invest Ophthalmol Vis Sci (2004) 1.12

Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma. Acta Ophthalmol (2009) 1.11

Problems associated with the 25-gauge transconjunctival sutureless vitrectomy system during and after surgery. Ophthalmologica (2006) 1.10

Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endocrinol (2004) 1.10

Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One (2010) 1.10

Long-term visual outcome and prognostic factors after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy. Am J Ophthalmol (2013) 1.08

Guideline for capsule endoscopy: obscure gastrointestinal bleeding. Clin Endosc (2013) 1.08

Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem (2007) 1.07

Severe hypoglycemia is a serious complication and becoming an economic burden in diabetes. Diabetes Metab J (2012) 1.07

Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev (2009) 1.04

Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci (2012) 1.04

In vitro inhibitory activities of essential oils from two Korean thymus species against antibiotic-resistant pathogens. Arch Pharm Res (2005) 1.03

Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents. Biosci Biotechnol Biochem (2003) 1.02

Retracted Endoscopic resection for rectal carcinoid tumors: comparison of polypectomy and endoscopic submucosal resection with band ligation. Clin Endosc (2012) 1.02

Influence of cataract on time domain and spectral domain optical coherence tomography retinal nerve fiber layer measurements. J Glaucoma (2012) 1.01

[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection]. Korean J Hepatol (2008) 1.01

Retinal detachment with macular hole following combined photodynamic therapy and intravitreal bevacizumab injection. Korean J Ophthalmol (2007) 1.00

Factors associated with false positives in retinal nerve fiber layer color codes from spectral-domain optical coherence tomography. Ophthalmology (2011) 0.98

Current status of endoscopic submucosal dissection for the management of early gastric cancer: a Korean perspective. World J Gastroenterol (2011) 0.98

Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation. Biochem Biophys Res Commun (2011) 0.97

Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro. FEBS Lett (2010) 0.97

Short-term safety and efficacy of a single intravitreal bevacizumab injection for the management of polypoidal choroidal vasculopathy. Ophthalmologica (2008) 0.97

Determinants of perimacular inner retinal layer thickness in normal eyes measured by Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 0.96

Descemet's membrane detachment associated with inadvertent viscoelastic injection in viscocanalostomy. Yonsei Med J (2002) 0.96

Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2010) 0.95

Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2012) 0.95

Structural and functional predictors of visual outcome of epiretinal membrane surgery. Am J Ophthalmol (2011) 0.94

Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Am J Ophthalmol (2012) 0.94

CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas. Biochem Biophys Res Commun (2011) 0.94

Early fetal development of the human cerebellum. Surg Radiol Anat (2011) 0.94

Cortical laminar necrosis caused by rapidly corrected hyponatremia. J Neuroimaging (2008) 0.93

AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am J Physiol Renal Physiol (2013) 0.93

Protective Effect of Proanthocyanidin against Diabetic Oxidative Stress. Evid Based Complement Alternat Med (2011) 0.93

Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy. J Ocul Pharmacol Ther (2009) 0.92

3- and 4-alkylphenol degradation pathway in Pseudomonas sp. strain KL28: genetic organization of the lap gene cluster and substrate specificities of phenol hydroxylase and catechol 2,3-dioxygenase. Microbiology (2003) 0.92

Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study. Clin Orthop Relat Res (2008) 0.91

Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization. Retina (2012) 0.90

Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy. Acta Ophthalmol (2008) 0.90

Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma (2012) 0.90

Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma. Eur J Gastroenterol Hepatol (2015) 0.89

C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. J Stroke Cerebrovasc Dis (2012) 0.89

Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol (2012) 0.89

Altered thalamocortical functional connectivity in idiopathic generalized epilepsy. Epilepsia (2014) 0.88

Hypokalemic periodic paralysis associated with thyrotoxicosis, renal tubular acidosis and nephrogenic diabetes insipidus. Endocr J (2010) 0.88

Ab externo direct suture technique for dislocated intraocular lens. J Cataract Refract Surg (2007) 0.88

Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1. Biochem Biophys Res Commun (2008) 0.88

Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion. Retina (2008) 0.87

Human fetal hyoid body origin revisited. J Anat (2011) 0.87

Evaluation of morroniside, iridoid glycoside from Corni Fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice. Biol Pharm Bull (2011) 0.87

Umbilical cord blood mesenchymal stem cells protect amyloid-β42 neurotoxicity via paracrine. World J Stem Cells (2012) 0.87

A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells. Biochem Biophys Res Commun (2010) 0.87

Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol. Atherosclerosis (2012) 0.86

Learning curve of capsule endoscopy. Clin Endosc (2013) 0.86

Development of the rectus abdominis and its sheath in the human fetus. Yonsei Med J (2012) 0.86

Hepato-protective effects of loganin, iridoid glycoside from Corni Fructus, against hyperglycemia-activated signaling pathway in liver of type 2 diabetic db/db mice. Toxicology (2011) 0.86

Redox-active porous metal-organic framework producing silver nanoparticles from AgI ions at room temperature. Angew Chem Int Ed Engl (2005) 0.86

Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage. Yonsei Med J (2007) 0.86

The role of microRNAs in hepatitis C virus replication and related liver diseases. J Microbiol (2014) 0.86

Postural instability and cognitive dysfunction in early Parkinson's disease. Can J Neurol Sci (2012) 0.86

Spatiotemporospectral characteristics of scalp ictal EEG in mesial temporal lobe epilepsy with hippocampal sclerosis. Brain Res (2009) 0.86

Scleral fixation of standard capsular tension ring and in-the-bag intraocular lens implantation in patients with severe lens subluxation. Ophthalmic Surg Lasers Imaging (2012) 0.85

Changes in chondrogenic phenotype and gene expression profiles associated with the in vitro expansion of human synovium-derived cells. J Orthop Res (2010) 0.85

Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery. Gynecol Oncol (2011) 0.85

Osteogenesis induced by a bone forming peptide from the prodomain region of BMP-7. Biomaterials (2012) 0.85

The Utility of HbA1c as a Diagnostic Criterion of Diabetes. Korean J Fam Med (2011) 0.85

Indication for endoscopic treatment of ulcerative early gastric cancer according to depth of ulcer and morphological change. J Gastroenterol Hepatol (2012) 0.85

Improvement of photoreceptor integrity and associated visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol (2012) 0.84

Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase. J Virol (2013) 0.84

Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci (2014) 0.84

Central serous chorioretinopathy after renal transplantation. Retina (2011) 0.84

Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results. Retina (2007) 0.84

Hypercholesterolemia accelerates amyloid β-induced cognitive deficits. Int J Mol Med (2013) 0.84

Protective effect of hexane extracts of Uncaria sinensis against photothrombotic ischemic injury in mice. J Ethnopharmacol (2011) 0.84

[Physician factors associated with the blood pressure control among hypertensive patients]. J Prev Med Public Health (2007) 0.84

Lymphocyte subpopulations in the liver, spleen, intestines, and mesenteric nodes: an immunohistochemical study using human fetuses at 15-16 weeks. Anat Rec (Hoboken) (2014) 0.84

Comparison of the optic nerve imaging by time-domain optical coherence tomography and Fourier-domain optical coherence tomography in distinguishing normal eyes from those with glaucoma. J Glaucoma (2013) 0.83